All In MedTech

Device Trial Radar · NCT04595838

A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis

A Randomized, Prospective, Multi-center Trial to Assess the Efficacy of a Cryotherapy Device Versus Best Supportive Oral Care in Mitigating Symptoms of Oral Mucositis in Patients Receiving Chemotherapy for the Treatment of Cancer

Last checked: Nov 19, 2026Latest source record: Sep 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 176 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

176

Actual

Start

Aug 31, 2020

Primary completion

May 18, 2023

Study completion May 18, 2023

Sponsor

Lead sponsor
Chemo MouthpieceNot on our public-company list
Sponsor type
Industry
First posted
Oct 22, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare the use of the Chemo MouthpieceTM device along with best supportive oral care to best supportive oral care alone to rate the effectiveness of Chemo MouthpieceTM in lessening symptoms associated with chemotherapy regimen known to place patients at risk for symptomatic mucositis and, of those, chemotherapy regimens for which ice-based cryotherapy has been demonstrated to have a favorable impact on oral mucositis symptom management. Subjects who are receiving standard chemotherapy regimens will be randomly assigned to receive either study device and oral care ingredients or oral care ingredients only. All subjects will complete daily diaries for the first 14 days of chemotherapy Cycles 1 and 2. Subjects who are assigned to the study device arm will use the device during their chemotherapy infusion in clinic and will continue to use the device at home ,at least twice daily, for the first six (6) days of chemotherapy Cycles 1 and 2. Prior to the first chemotherapy infusion in Cycle 3, all subjects in the study regardless of treatment assignment will have the option of using the Chemo MouthpieceTM for subsequent cycles.

Conditions

  • Oral Mucositis

Interventions

  • Chemo MouthpieceDevice

    Frozen tube that fills the oral cavity used during and after chemotherapy to ease and prevent symptoms of oral mucositis

  • Best Supportive Care onlyOther

    Standard Oral care for Chemotherapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of oral mucositis symptomatic events observed during the first cycle of chemotherapy.Time frame: Cycle 1 of chemotherapy (14-28 days, time frame varies based on regimen)
  2. The incidence of oral mucositis symptomatic events observed during the second cycle of chemotherapy.Time frame: Cycle 2 of chemotherapy (14-28 days, time frame varies based on regimen)
  3. The incidence of severe oral mucositis symptomatic events observed during the first cycle of chemotherapy.Time frame: Cycle 1 of chemotherapy (14-28 days, time frame varies based on regimen)

1 more outcomes with a free account

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Chan Soon-Shiong Institute for Medicine

    Costa Mesa, California

  • Goshen Health

    Goshen, Indiana

  • Revive Research Institute

    Farmington Hills, Michigan

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.